Not independent
Tenure on this board
4.6 yrs
12 nominees · 2 ballot items.
Adopt an amendment to effect a reverse stock split of common stock at a ratio between 1-for-2 and 1-for-30 with the exact ratio and timing determined by the board; and approve adjournment of the special meeting if necessary to solicit additional votes for Proposal 1.
Amend the Restated Certificate of Incorporation to authorize a reverse stock split of common stock at a ratio within the range of 1-for-2 to 1-for-30, with the exact ratio and timing to be determined by the board within one year of approval.
This management proposal asks stockholders to approve an amendment to the company’s Restated Certificate of Incorporation to permit the board to implement a reverse stock split at any ratio between 1-for-2 and 1-for-30 within one year of approval, with the precise ratio and timing at the board’s discretion. The board is seeking this authority primarily to increase the per-share market price to comply with Nasdaq’s $1.00 minimum bid price requirement and to avoid potential delisting, which it views as critical to maintain liquidity, institutional interest, and the company’s ability to raise capital. The proposal notes past Nasdaq communications and the company’s transfer to the Nasdaq Capital Market with a March 30, 2026 deadline to regain compliance. The board evaluated both benefits (maintaining listing, attracting institutional investors, improving perceived share value) and risks (negative market perceptions of reverse splits, potential for post-split price declines, reduced liquidity, implementation costs), concluding that the benefits outweigh the risks. If authorized, the board may elect any one ratio within the approved range and will publicly announce the selected ratio prior to filing the amendment; only one reverse split may be effected under the authorization. The board recommends a FOR vote, reasoning that the flexibility to choose the ratio and timing enables them to act opportunistically to meet Nasdaq requirements and maximize shareholder value, while retaining the discretion to abandon the split if conditions change or it is no longer advisable.
Authorize the proxies to adjourn or postpone the special meeting to solicit additional proxies if there are insufficient votes to approve the reverse stock split (Proposal 1).
This management proposal requests authorization to adjourn or postpone the special meeting so that the company can solicit additional proxies if there are insufficient votes to approve the reverse stock split (Proposal 1). The board argues that adjournment is in stockholders’ best interests because it provides an opportunity to gather additional support for the reverse split, potentially avoiding the negative consequences of failing to implement a split that may be necessary to maintain Nasdaq listing. Approval would permit the holders of proxies solicited by the board to vote in favor of adjourning the meeting and would allow the board to use extra time to solicit votes, including from holders who may initially oppose Proposal 1. The board recommends a FOR vote, asserting that this procedural authorization is a standard mechanism to ensure sufficient time for shareholder consideration and to protect shareholder value by avoiding a failed vote on a material governance action.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 11.10% | 664,021 | $6M |
| 2 | GILEAD SCIENCES, INC. | 10.87% | 650,389 | $5M |
| 3 | Frazier Life Sciences Management, L.P. | 7.06% | 422,505 | $4M |
| 4 | Sio Capital Management, LLC | 2.55% | 152,464 | $1M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.07% | 123,660 | $1M |
| 6 | Caligan Partners LPActivist | 1.87% | 112,128 | $943K |
| 7 | Merck Co., Inc. | 1.77% | 105,982 | $891K |
| 8 | Stonepine Capital Management, LLC | 1.07% | 64,162 | $540K |
| 9 | MORGAN STANLEY | 0.96% | 57,493 | $484K |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 0.83% | 49,566 | $417K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.